Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
6.67
-0.92 (-12.12%)
At close: Mar 31, 2025, 4:00 PM
6.51
-0.16 (-2.40%)
After-hours: Mar 31, 2025, 4:45 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-258.75-245.6-221.86-169.07-139.7
Upgrade
Depreciation & Amortization
9.387.16.275.376.25
Upgrade
Other Amortization
---0.752.76
Upgrade
Asset Writedown & Restructuring Costs
-0.890.240.260.42
Upgrade
Loss (Gain) From Sale of Investments
-8.07-10.170.132.890.58
Upgrade
Stock-Based Compensation
43.9239.4131.0129.2418.57
Upgrade
Other Operating Activities
1.88-0.36-12.7826.56
Upgrade
Change in Accounts Payable
6.0710.159.67-4.8311.02
Upgrade
Change in Other Net Operating Assets
-4.153.68-3.61.44-1.09
Upgrade
Operating Cash Flow
-209.72-194.92-178.14-121.16-74.64
Upgrade
Capital Expenditures
-5.86-16.44-8.36-7.62-20.61
Upgrade
Cash Acquisitions
--42.73--
Upgrade
Investment in Securities
137.57-81.59-103.4326.57-67.53
Upgrade
Other Investing Activities
--0.04-0.26-0.1-8.45
Upgrade
Investing Cash Flow
131.71-98.07-69.3318.85-96.59
Upgrade
Issuance of Common Stock
185.74208.4155.3437.68283.91
Upgrade
Repurchase of Common Stock
---0.05--0.69
Upgrade
Other Financing Activities
-----0.24
Upgrade
Financing Cash Flow
185.74208.4155.2937.68282.99
Upgrade
Net Cash Flow
107.72-84.58-92.18-64.63111.76
Upgrade
Free Cash Flow
-215.59-211.35-186.5-128.78-95.25
Upgrade
Free Cash Flow Per Share
-2.27-2.52-2.74-2.04-1.72
Upgrade
Cash Interest Paid
---0.152.96
Upgrade
Levered Free Cash Flow
-133.26-119.77-99.45-82.57-74.19
Upgrade
Unlevered Free Cash Flow
-132.08-118.6-98.29-81.47-72.6
Upgrade
Change in Net Working Capital
8.76-11.75-12.74.55-7.13
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q